Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Clodronic acid
Drug ID BADD_D00494
Description Clodronic acid is a first generation bisphosphonate similar to [etidronic acid] and [tiludronic acid].[A203111] These drugs were developed to mimic the action of pyrophosphate, a regulator of calcification and decalcification.[A1923] clodronate’s use has decreased over the years in favor of the third generation, nitrogen containing bisphosphonate [zoledronic acid], [ibandronic acid], [minodronic acid], and [risedronic acid].[A203111] Clodronic acid is not FDA approved, but is approved in Canada.[L13910]
Indications and Usage For the management of hypercalcemia of malignancy and as an adjunct in the management of osteolysis resulting from bone metastases of malignant tumors.
Marketing Status Not Available
ATC Code M05BA02
DrugBank ID DB00720
KEGG ID D03545
MeSH ID D004002
PubChem ID 25419
TTD Drug ID D00HNB
NDC Product Code Not Available
Synonyms Clodronic Acid | Acid, Clodronic | Dichloromethane Diphosphonate | Diphosphonate, Dichloromethane | Dichloromethylenebisphosphonate | Dichloromethanediphosphonic Acid | Acid, Dichloromethanediphosphonic | Dichloromethylene Biphosphonate | Biphosphonate, Dichloromethylene | Dichloromethylene Diphosphonate | Diphosphonate, Dichloromethylene | Cl2MDP | Dichloromethanediphosphonate | Clodronate | Clodronate Disodium | Disodium, Clodronate | Clodronate Sodium | Sodium, Clodronate | Bonefos
Chemical Information
Molecular Formula CH4Cl2O6P2
CAS Registry Number 10596-23-3
SMILES C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.003--
Acute leukaemia16.01.02.001; 01.10.02.001--Not Available
Acute myeloid leukaemia16.01.05.001; 01.10.05.001--Not Available
Alanine aminotransferase increased13.03.01.003--
Anaemia01.03.02.001--
Angioedema23.04.01.001; 10.01.05.009--Not Available
Blood creatinine increased13.13.01.004--
Bronchospasm22.03.01.004; 10.01.03.012--
Cardiac failure02.05.01.001--
Death08.04.01.001--
Dehydration14.05.05.001--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Dyspepsia07.01.02.001--
Dysphagia07.01.06.003--
Dyspnoea22.02.01.004; 02.01.03.002--
Extravasation08.01.03.008--Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Hepatic function abnormal09.01.02.001--Not Available
Hepatocellular injury09.01.07.008--Not Available
Hypercalcaemia14.04.01.003; 05.04.01.002--
Hyperparathyroidism secondary20.01.01.006; 05.04.01.004--Not Available
Hyperphosphataemia14.04.03.007--
Hypocalcaemia14.04.01.004--
Infection11.01.08.002--Not Available
Liver disorder09.01.08.001--Not Available
Local reaction08.01.03.012--Not Available
Metastases to liver16.22.02.001; 09.04.02.004--Not Available
Myeloid leukaemia16.01.08.001; 01.10.08.001--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages